{
    "clinical_study": {
        "@rank": "4705", 
        "arm_group": {
            "arm_group_label": "Inhaled anaesthetic agent", 
            "arm_group_type": "Experimental", 
            "description": "The group where the investigators adds inhaled anaesthetic agent when using the anaesthetic gas reflector (AnaConda)."
        }, 
        "brief_summary": {
            "textblock": "The purpose is to investigate how the adsorptive capacity of the active carbon filter to\n      carbon dioxide in an anaesthetic gas reflector (AnaConDa) is affected by adding inhaled\n      anaesthetic agent.\n\n      The hypothesis is that addition of inhaled anaesthetic agent will affect the amount of\n      adsorption of carbon dioxide to the active carbon and thereby affect rebreathing of carbon\n      dioxide."
        }, 
        "brief_title": "Influence of Inhaled Anaesthetics on Rebreathing of Carbon Dioxide When Using an Anaesthesia Gas Reflector (AnaConDa)", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Ischemic Heart Disease", 
        "condition_browse": {
            "mesh_term": [
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Heart Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  elective coronary artery by-pass graft surgery\n\n          -  elective valve replacement surgery\n\n          -  normal left ventricular ejection fraction on preoperative echocardiography\n\n        Exclusion Criteria:\n\n          -  obstructive lung disease\n\n          -  restrictive lung disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 25, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01699802", 
            "org_study_id": "2012/148"
        }, 
        "intervention": {
            "arm_group_label": "Inhaled anaesthetic agent", 
            "intervention_name": "Inhaled anaesthetic agent", 
            "intervention_type": "Other"
        }, 
        "intervention_browse": {
            "mesh_term": "Anesthetics"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 4, 2014", 
        "location": {
            "contact": {
                "email": "louise.walther_sturesson@med.lu.se", 
                "last_name": "Louise C Walther Sturesson, M.D.", 
                "phone": "+46 46 171953"
            }, 
            "facility": {
                "address": {
                    "city": "Lund", 
                    "country": "Sweden", 
                    "zip": "SE-221 85"
                }, 
                "name": "Skane University Hospital Lund, Cardiothoracic Intensive Care"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "1", 
        "official_title": "Influence of Inhaled Anaesthetics on Rebreathing of Carbon Dioxide When Using an Anaesthesia Gas Reflector (AnaConDa)", 
        "overall_contact": {
            "email": "gunnar.malmkvist@skane.se", 
            "last_name": "Gunnar Malmkvist, M.D.  Ph.D.", 
            "phone": "+46 46 171035"
        }, 
        "overall_official": {
            "affiliation": "Divison of Surgery, Department of Anaesthesia, Skane University Hospital, Lund, Sweden", 
            "last_name": "Mikael Bodelsson, Professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Sweden: Medical Products Agency", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Tidal carbon dioxide volume rebreathed from an anesthetic gas reflector correlated to concentration of delivered anesthetic gas.", 
            "measure": "Volume of carbon dioxide rebreathing from an anesthetic gas reflector", 
            "safety_issue": "No", 
            "time_frame": "2 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01699802"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Changes of tidal volume required to maintain constant alveolar ventilation will be assessed by continuous measurement of exhaled tidal carbon dioxide volume, the latter to be maintained at a constant value.", 
            "measure": "Quantification of ventilatory requirements to maintain isocapnia with the use of an anesthetic gas reflector.", 
            "safety_issue": "No", 
            "time_frame": "2 hours"
        }, 
        "source": "Region Skane", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Region Skane", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}